Cargando…
Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy
Clinical improvement in stem cell gene therapy (SCGT) for primary immunodeficiencies depends on the engraftment levels of genetically corrected cells, and tracing the transgene in each hematopoietic lineage is therefore extremely important in evaluating the efficacy of SCGT. We established a single...
Autores principales: | Igarashi, Yuka, Uchiyama, Toru, Minegishi, Tomoko, Takahashi, Sirirat, Watanabe, Nobuyuki, Kawai, Toshinao, Yamada, Masafumi, Ariga, Tadashi, Onodera, Masafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466583/ https://www.ncbi.nlm.nih.gov/pubmed/28626778 http://dx.doi.org/10.1016/j.omtm.2017.05.005 |
Ejemplares similares
-
Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clones
por: Uchiyama, Toru, et al.
Publicado: (2021) -
Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open‐label, single‐arm, phase 3, and postmarketing clinical study
por: Onodera, Masafumi, et al.
Publicado: (2023) -
Maternal T-cell engraftment impedes with diagnosis of a SCID-ADA patient
por: Lanfranchi, Arnalda, et al.
Publicado: (2018) -
Evaluation of clonal hematopoiesis in pediatric ADA-SCID gene therapy participants
por: White, Shanna L., et al.
Publicado: (2022) -
Chronic granulomatous disease with pulmonary mass-like opacities secondary to hypersensitivity pneumonitis: a case report
por: Katsuya, Yuki, et al.
Publicado: (2014)